Buy Glenmark Pharmaceuticals, target Rs 666: Kunal Bothra
ETMarkets.com|
Jan 24, 2018, 09.08 AM IST
Independent analyst Kunal Bothra has a buy call on Glenmark Pharmaceuticals with a target price of Rs 666.
The current market price of Glenmark Pharmaceuticals is Rs 631.70.
Time period given by the analyst is 'Intra Day' when Glenmark Pharmaceuticals price can reach defined target.
Kunal Bothra recommended to keep a stop loss at Rs 615.
Glenmark Pharmaceuticals, incorporated in the year 1977, is a Large Cap company (having a market cap of Rs 17,824.56 Crore) operating in Pharmaceuticals and health care sector.
The company's top management includes Dr.Brian W Tempest, Mr.Bernard Munos, Mr.D R Mehta, Mr.Glenn Saldanha, Mr.Julio Ribeiro, Mr.Milind Sarwate, Mr.Murali Neelakantan, Mr.Rajesh V Desai, Mr.Sridhar Gorthi, Mrs.B E Saldanha, Mrs.Cherylann Pinto.
Company has Walker, Chandiok & Co.LLP as its auditors.
As on 31-12-2017, the company has a total of 282,168,156 shares outstanding.
The current market price of Glenmark Pharmaceuticals is Rs 631.70.
Time period given by the analyst is 'Intra Day' when Glenmark Pharmaceuticals price can reach defined target.
Kunal Bothra recommended to keep a stop loss at Rs 615.
Glenmark Pharmaceuticals, incorporated in the year 1977, is a Large Cap company (having a market cap of Rs 17,824.56 Crore) operating in Pharmaceuticals and health care sector.
The company's top management includes Dr.Brian W Tempest, Mr.Bernard Munos, Mr.D R Mehta, Mr.Glenn Saldanha, Mr.Julio Ribeiro, Mr.Milind Sarwate, Mr.Murali Neelakantan, Mr.Rajesh V Desai, Mr.Sridhar Gorthi, Mrs.B E Saldanha, Mrs.Cherylann Pinto.
Company has Walker, Chandiok & Co.LLP as its auditors.
As on 31-12-2017, the company has a total of 282,168,156 shares outstanding.
Read this article in :Hindi
